FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Herbert Lepor

Research Profile

Procedures

Disorders

Anatomy

Chemicals & Drugs

Concepts & Ideas

Activities & Behaviors

Questionnaires

Co-author Network

Publications

TOP 3
Vinay Prabhu; Danil V Makarov; Joseph P Alukal; Juliana Laze; Herbert Lepor
Long-term satisfaction and predictors of use of intracorporeal injections for post-prostatectomy erectile dysfunction.
Eugene W Lee; Ilir Agalliu; Juliana Laze; Tracy Marien; Herbert Lepor
Comparison of health-related quality-of-life outcomes for African-American and Caucasian-American men after radical prostatectomy.
Alon Y Mass; Ilir Agalliu; Juliana Laze; Herbert Lepor
Preoperative statin therapy is not associated with biochemical recurrence after radical prostatectomy: our experience and meta-analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Herbert Lepor (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Vinay Prabhu; Danil V Makarov; Joseph P Alukal; Juliana Laze; Herbert Lepor
Long-term satisfaction and predictors of use of intracorporeal injections for post-prostatectomy erectile dysfunction.
The Journal of urology 2013;189(1):238-42.
2012: Eugene W Lee; Ilir Agalliu; Juliana Laze; Tracy Marien; Herbert Lepor
Comparison of health-related quality-of-life outcomes for African-American and Caucasian-American men after radical prostatectomy.
BJU international 2012;110(8):1129-33.
2012: Alon Y Mass; Ilir Agalliu; Juliana Laze; Herbert Lepor
Preoperative statin therapy is not associated with biochemical recurrence after radical prostatectomy: our experience and meta-analysis.
The Journal of urology 2012;188(3):786-91.
2012: Bob Djavan; James A Eastham; Leonard Gomella; Amir Kazzazi; Herbert Lepor; Judd Moul; Neal Shore; Samir Taneja; Bertrand Tombal; Per-Anders Abrahamsson; Philippa Cheetham; Seyed Saeid Dianat; E David Crawford
Testosterone in prostate cancer: the Bethesda consensus.
BJU international 2012;110(3):344-52.
2012: Bob Djavan; Amir Kazzazi; Juliana Laze; Ilir Agalliu; Helen Sadri; Herbert Lepor
Blood loss during radical prostatectomy: impact on clinical, oncological and functional outcomes and complication rates.
BJU international 2012;110(1):69-75.
2012: Herbert Lepor; Leslie A Mangold; Daniel W Chan; Carol D Cheli; Juliana Laze; Lori J Sokoll; Samir S Taneja; Robert P Thiel; Alan W Partin
Clinical evaluation of a novel method for the measurement of prostate-specific antigen, AccuPSA(TM) , as a predictor of 5-year biochemical recurrence-free survival after radical prostatectomy: results of a pilot study.
BJU international 2012;109(12):1770-5.
2012: Bob Djavan; Amir Kazzazi; Herbert Lepor
BPH: predicting TWOC failure in acute urinary retention.
Nature reviews. Urology 2012;9(4):181-2.
2012: Herbert Lepor
Radical prostatectomy for long-term functional and oncologic outcomes.
European urology 2012;61(4):676-8.
2012: Rajat Jain; Juliana Laze; Sarah Mitchell; Herbert Lepor
The effect of surgical intervention for stress urinary incontinence (UI) on post-prostatectomy UI during sexual activity.
BJU international 2012;109(8):1208-12.
2012: Herbert Lepor
Editorial comment.
Urology 2012;79(2):338-9; author reply 339.
2012: Ganesh Sivarajan; Gary D Steinberg; Sam S Chang; Amr Fergany; S Bruce Malkowicz; Herbert Lepor
Lap pak for abdominal retraction.
Reviews in urology 2012;14(3-4):41-7.
2012: Herbert Lepor; Neal D Shore
LHRH Agonists for the Treatment of Prostate Cancer: 2012.
Reviews in urology 2012;14(1-2):1-12.
2012: Kun Xu; Lixia Zhang; Yan Deng; Duane Hickling; Honging Huang; Peng Lee (Li); Herbert Lepor; Juan Li; Ellen Shapiro; Xinyu Wu; Irina Grishina
Bmp7 functions via a polarity mechanism to promote cloacal septation.
PloS one 2012;7(1):e29372.
2012: Herbert Lepor; Amir Kazzazi; Bob Djavan
α-Blockers for benign prostatic hyperplasia: the new era.
Current opinion in urology 2012;22(1):7-15.
2011: Bob Djavan; Elisabeth Eckersberger; Julia Finkelstein; Juliana Laze; Ilir Agalliu; Herbert Lepor
The short-term use of erythropoetin-stimulating agents: impact on the biochemical recurrence of prostate cancer.
BJU international 2011;108(10):1582-7.
2011: Sarah A Mitchell; Rajat K Jain; Juliana Laze; Herbert Lepor
Post-prostatectomy incontinence during sexual activity: a single center prevalence study.
The Journal of urology 2011;186(3):982-5.
2011: E W Lee; J Laze; Herbert Lepor
Outcomes of extremely low risk prostate cancer following radical prostatectomy.
Prostate cancer and prostatic diseases 2011;14(3):266-9.
2011: Xinyu Wu; Kun Xu; Lixia Zhang; Yan Deng; Peng Lee (Li); Herbert Lepor; Juan Li; Helen P Makarenkova; Marie Monaco; Ellen Shapiro; Irina Grishina
Differentiation of the ductal epithelium and smooth muscle in the prostate gland are regulated by the Notch/PTEN-dependent mechanism.
Developmental biology 2011;356(2):337-49.
2011: Huihui Ye; Kenneth Choi; Tian Wei He; Timothy Jolis; Xiangtian Kong; Herbert Lepor; Jonathan Melamed
Intraoperative frozen section analysis of urethral margin biopsies during radical prostatectomy.
Urology 2011;78(2):399-404.
2011: Guilherme Godoy; Basir U. Tareen; Herbert Lepor
Is the apical soft tissue margin a better predictor of biochemical recurrence than the surgical specimen?
Urologic oncology 2011;29(4):388-92.
2011: Xinyu Wu; Garrett Daniels; Ellen Shapiro; Kun Xu; Hongying Huang; Yirong Li; Susan Logan; M Alba Greco; Yi Peng; Marie E Monaco; Jonathan Melamed; Herbert Lepor; Irina Grishina; Peng Lee (Li)
LEF1 identifies androgen-independent epithelium in the developing prostate.
Molecular endocrinology (Baltimore, Md.) 2011;25(6):1018-26.
2011: Andrew B Rosenkrantz; Benjamin E Niver; Martin Kopec; Douglas S Berkman; Herbert Lepor; James S Babb; Elizabeth M Hecht
T1 hyperintensity of bladder urine at prostate MRI: frequency and comparison with urinalysis findings.
Clinical imaging 2011;35(3):203-7.
2011: Herbert Lepor
Minimally invasive ablative therapies for the treatment of prostate cancer.
Reviews in urology 2011;13(1):61-2.
2011: Herbert Lepor
Medical treatment of benign prostatic hyperplasia.
Reviews in urology 2011;13(1):20-33.
2010: Herbert Lepor; Lawrence A Hill
Silodosin for the treatment of benign prostatic hyperplasia: pharmacology and cardiovascular tolerability.
Pharmacotherapy 2010;30(12):1303-12.
2010: Nitya E Abraham; Danil V Makarov; Juliana Laze; Elina Stefanovics; Rani Desai; Herbert Lepor
Patient centered outcomes in prostate cancer treatment: predictors of satisfaction up to 2 years after open radical retropubic prostatectomy.
The Journal of urology 2010;184(5):1977-81.
2010: Tracy Marien; Bachir Taouli; Shpetim Telegrafi; James Babb; Herbert Lepor
Optimizing the detection of subclinical inguinal hernias in men undergoing open radical retropubic prostatectomy.
BJU international 2010;106(10):1468-72.
2010: Herbert Lepor
Editorial comment.
Urology 2010;76(4):933.
2010: Bob Djavan; Elisabeth Eckersberger; Julia Finkelstein; Geovanni Espinosa; Helen Sadri; Roland Brandner; Ojas Shah; Herbert Lepor
Benign prostatic hyperplasia: current clinical practice.
Primary care 2010;37(3):583-97, ix.
2010: Bob Djavan; Elisabeth Eckersberger; Julia Finkelstein; Helen Sadri; Samir S Taneja; Herbert Lepor
Prostate-specific antigen testing and prostate cancer screening.
Primary care 2010;37(3):441-59, vii.
2010: Patrick Mufarrij; Alex Sankin; Guilherme Godoy; Herbert Lepor
Pathologic outcomes of candidates for active surveillance undergoing radical prostatectomy.
Urology 2010;76(3):689-92.
2010: Rena Malik; Juliana Laze; Herbert Lepor
The effect of local compression and topical epinephrine on perioperative bleeding and degree of urinary extravasation on postoperative cystogram following radical retropubic prostatectomy.
The Canadian journal of urology 2010;17(4):5272-7.
2010: Bob Djavan; Elisabeth Eckersberger; Markus Johannes Handl; Roland Brandner; Helen Sadri; Herbert Lepor
Durability and retreatment rates of minimal invasive treatments of benign prostatic hyperplasia: a cross-analysis of the literature.
The Canadian journal of urology 2010;17(4):5249-54.
2010: Herbert Lepor; Michael Lipkin; Denisa Slova
The preoperative use of erythropoietin stimulating proteins prior to radical prostatectomy is not associated with increased cardiovascular or thromboembolic morbidity or mortality.
Urology 2010;75(6):1424-8.
2010: Andrew R McCullough; Wayne G Hellstrom; Run Wang; Herbert Lepor; Kristofer R Wagner; Jason D Engel
Recovery of erectile function after nerve sparing radical prostatectomy and penile rehabilitation with nightly intraurethral alprostadil versus sildenafil citrate.
The Journal of urology 2010;183(6):2451-6.
2010: Herbert Lepor; Basir U. Tareen
Neurovascular bundle resection: does it improve the margins?
Urologic oncology 2010;28(2):215-8.
2010: Elisabeth Eckersberger; Herbert Lepor; Helen Sadri; Alexander Farr; Markus Margreiter; Mike Harik; Bob Djavan
Uro-oncological controversies in euro-oncology: highlights from the European association of urology section of oncological urology, january 15-17, 2010, vienna, austria.
Reviews in urology 2010;12(2-3):e125-8.
2010: Julia Finkelstein; Elisabeth Eckersberger; Helen Sadri; Samir S Taneja; Herbert Lepor; Bob Djavan
Open Versus Laparoscopic Versus Robot-Assisted Laparoscopic Prostatectomy: The European and US Experience.
Reviews in urology 2010;12(1):35-43.
2010: Shpetim Telegrafi; Timothy Ito; Mariana Kozirovsky; Juliana Laze; Herbert Lepor
Transperineal sonocystography: new standard for assessing anastomotic leaks after radical prostatectomy.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2010;29(1):71-7.
2010: Rebecca L O'Malley; Shpetim Telegrafi; Juliana Laze; Herbert Lepor
Para-anastomotic haematoma volume predicts the presence of anastomotic extravasation after radical retropubic prostatectomy.
BJU international 2010;105(1):34-6.
2009: Feng He; Lan Mo; Xiao-Yong Zheng; Changkun Hu; Herbert Lepor; Eva Y-H P Lee; Tung-Tien Sun; Xue-Ru Wu
Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis.
Cancer research 2009;69(24):9413-21.
2009: Seyed S Dianat; Markus Margreiter; Elisabeth Eckersberger; Julia Finkelstein; Franklin Kuehas; Ralf Herwig; Mohsen Ayati; Herbert Lepor; Bob Djavan
Gene polymorphisms and prostate cancer: the evidence.
BJU international 2009;104(11):1560-72.
2009: Guilherme Godoy; Basir U. Tareen; Herbert Lepor
Site of positive surgical margins influences biochemical recurrence after radical prostatectomy.
BJU international 2009;104(11):1610-4.
2009: Guilherme Godoy; Basir U. Tareen; Herbert Lepor
Does benign prostatic tissue contribute to measurable PSA levels after radical prostatectomy?
Urology 2009;74(1):167-70.
2009: Basir U. Tareen; Guilherme Godoy; Alex Sankin; Steve Temkin; Herbert Lepor; Samir S Taneja
Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?
BJU international 2009;104(2):195-9.
2009: Tracy Marien; Alex Sankin; Herbert Lepor
Factors predicting preservation of erectile function in men undergoing open radical retropubic prostatectomy.
The Journal of urology 2009;181(4):1817-22.
2009: Basir U. Tareen; Guilherme Godoy; Alex Sankin; Steve Temkin; Herbert Lepor; Samir S Taneja
Laterality alone should not drive selection of candidates for hemi-ablative focal therapy.
The Journal of urology 2009;181(3):1082-9; discussion 1089-90.
2009: Leonard Glickman; Guilherme Godoy; Herbert Lepor
Changes in continence and erectile function between 2 and 4 years after radical prostatectomy.
The Journal of urology 2009;181(2):731-5.
2009: Basir U. Tareen; Alex Sankin; Guilherme Godoy; Steve Temkin; Herbert Lepor; Samir S Taneja
Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in contemporary cohort.
Urology 2009;73(2):351-4; discussion 354-5.
2009: Herbert Lepor
Pathophysiology of benign prostatic hyperplasia: insights from medical therapy for the disease.
Reviews in urology 2009;11(Suppl 1):S9-S13.
2009: Micah L Hemani; Herbert Lepor
Skin preparation for the prevention of surgical site infection: which agent is best?
Reviews in urology 2009;11(4):190-5.
2009: Herbert Lepor
Advances in the medical treatment of benign prostatic hyperplasia.
Reviews in urology 2009;11(4):181-4.
2009: Elisabeth Eckersberger; Julia Finkelstein; Helen Sadri; Markus Margreiter; Samir S Taneja; Herbert Lepor; Bob Djavan
Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials.
Reviews in urology 2009;11(3):127-33.
2009: Herbert Lepor
Status of radical prostatectomy in 2009: is there medical evidence to justify the robotic approach?
Reviews in urology 2009;11(2):61-70.
2009: A Sankin; Basir U. Tareen; Herbert Lepor
Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy.
Prostate cancer and prostatic diseases 2009;12(2):204-8.
2008: Herbert Lepor; Mariana Kozirovsky; Juliana Laze; Shpetim Telegrafi
Transabdominal sonocystography: a novel technique to assess vesicourethral extravasation following radical prostatectomy.
The Journal of urology 2008;180(6):2459-62.
2008: Tracy P Marien; Herbert Lepor
Does a nerve-sparing technique or potency affect continence after open radical retropubic prostatectomy?
BJU international 2008;102(11):1581-4.
2008: Basir U. Tareen; Guilherme Godoy; Juliana Laze; Herbert Lepor
Does open radical retropubic prostatectomy decrease the risk of acute urinary retention?
Urology 2008;72(4):821-4.
2008: Nicholas J Sanfilippo; Samir S Taneja; Abraham Chachoua; Herbert Lepor; Silvia C Formenti
Phase I/II study of biweekly paclitaxel and radiation in androgen-ablated locally advanced prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(18):2973-8.
2008: Mark A Perlmutter; Herbert Lepor
Prostate-specific antigen doubling time is a reliable predictor of imageable metastases in men with biochemical recurrence after radical retropubic prostatectomy.
Urology 2008;71(3):501-5.
2008: Tracy P Marien; Ellen Shapiro; Jonathan Melamed; Bachir Taouli; Michael D Stifelman; Herbert Lepor
Management of localized prostate cancer and an incidental ureteral duplication with upper pole ectopic ureter inserting into the prostatic urethra.
Reviews in urology 2008;10(4):297-303.
2008: Herbert Lepor
Vascular targeted photodynamic therapy for localized prostate cancer.
Reviews in urology 2008;10(4):254-61.
2008: Herbert Lepor; Andrew McCullough; Jason D Engel
Renewing intimacy: advances in treating erectile dysfunction postprostatectomy.
Reviews in urology 2008;10(4):245-53.
2008: Herbert Lepor; Norman E Lepor; Lawrence A Hill; Richard Gary Trohman
The QT Interval and Selection of Alpha-Blockers for Benign Prostatic Hyperplasia.
Reviews in urology 2008;10(2):85-91.
2008: Herbert Lepor; Andrew McCullough
Penile Rehabilitation Postprostatectomy: Is There a Role for MUSE?
Reviews in urology 2008;10(1):1-5.
2007: Denisa Slova; Herbert Lepor
The short-term and long-term effects of radical prostatectomy on lower urinary tract symptoms.
The Journal of urology 2007;178(6):2397-400; discussion 2400-1.
2007: Herbert Lepor; David Robbins
Inguinal hernias in men undergoing open radical retropubic prostatectomy.
Urology 2007;70(5):961-4.
2007: Hong-Ying Huang; Shahrokh F Shariat; Tung-Tien Sun; Herbert Lepor; Ellen Shapiro; Jer-Tsong Hsieh; Raheela Ashfaq; Yair Lotan; Xue-Ru Wu
Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome.
Human pathology 2007;38(11):1703-13.
2007: Lan Mo; Xiaoyong Zheng; Hong-Ying Huang; Ellen Shapiro; Herbert Lepor; Carlos Cordon-Cardo; Tung-Tien Sun; Xue-Ru Wu
Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis.
The Journal of clinical investigation 2007;117(2):314-25.
2007: Herbert Lepor
Alpha blockers for the treatment of benign prostatic hyperplasia.
Reviews in urology 2007;9(4):181-90.
2007: Jamie A Kanofsky; Herbert Lepor
Spontaneous renal artery dissection.
Reviews in urology 2007;9(3):156-60.
2007: Mark A Perlmutter; Herbert Lepor
Androgen deprivation therapy in the treatment of advanced prostate cancer.
Reviews in urology 2007;9 Suppl 1():S3-8.
2006: Raymond Sultan; Denisa Slova; Bob Thiel; Herbert Lepor
Time to return to work and physical activity following open radical retropubic prostatectomy.
The Journal of urology 2006;176(4 Pt 1):1420-3.
2006: Ken Goto; Sarah N Salm; Sandra Coetzee; Xiaozhong Xiong; Patricia E Burger; Ellen Shapiro; Herbert Lepor; David Moscatelli; E Lynette Wilson
Proximal prostatic stem cells are programmed to regenerate a proximal-distal ductal axis.
Stem cells (Dayton, Ohio) 2006;24(8):1859-68.
2006: George Huang; Herbert Lepor
Factors predisposing to the development of anastomotic strictures in a single-surgeon series of radical retropubic prostatectomies.
BJU international 2006;97(2):255-8.
2006: Herbert Lepor
The evolution of alpha-blockers for the treatment of benign prostatic hyperplasia.
Reviews in urology 2006;8 Suppl 4():S3-9.
2006: David M Fenig; Denisa Slova; Herbert Lepor
Postoperative blood loss predicts the development of urinary extravasation on cystogram following radical retropubic prostatectomy.
The Journal of urology 2006;175(1):146-50; discussion 150.
2005: Jeremy D Kaufman; Herbert Lepor
Reoperation versus observation in men with major bleeding after radical retropubic prostatectomy.
Urology 2005;66(3):561-5.
2005: Christian Twiss; Denisa Slova; Herbert Lepor
Outcomes for men younger than 50 years undergoing radical prostatectomy.
Urology 2005;66(1):141-6.
2005: Rupa Patel; Herbert Lepor; Robert P Thiel; Samir S Taneja
Prostate-specific antigen velocity accurately predicts response to salvage radiotherapy in men with biochemical relapse after radical prostatectomy.
Urology 2005;65(5):942-6.
2005: Samson Shen; Herbert Lepor; Robert Yaffee; Samir S Taneja
Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy.
The Journal of urology 2005;173(3):777-80.
2004: Ellen Shapiro; Hongying Huang; Deborah E McFadden; Rachel J. Masch; Eliza Ng; Herbert Lepor; Xue-Ru Wu
The prostatic utricle is not a Müllerian duct remnant: immunohistochemical evidence for a distinct urogenital sinus origin.
The Journal of urology 2004;172(4 Pt 2):1753-6; discussion 1756.
2004: Chris J Schettino; Elissa L Kramer; Marilyn E Noz; Samir Taneja; Priya Padmanabhan; Herbert Lepor
Impact of fusion of indium-111 capromab pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer.
AJR. American journal of roentgenology 2004;183(2):519-24.
2004: Herbert Lepor; Ledia Kaci
Role of intraoperative biopsies during radical retropubic prostatectomy.
Urology 2004;63(3):499-502.
2004: Herbert Lepor; Ledia Kaci
The impact of open radical retropubic prostatectomy on continence and lower urinary tract symptoms: a prospective assessment using validated self-administered outcome instruments.
The Journal of urology 2004;171(3):1216-9.
2004: Herbert Lepor; Ledia Kaci; Xiaonan Xue
Continence following radical retropubic prostatectomy using self-reporting instruments.
The Journal of urology 2004;171(3):1212-5.
2004: Herbert Lepor
Radical prostatectomy: status and opportunities for improving outcomes.
Cancer investigation 2004;22(3):435-44.
2003: Yoshio Naya; Herbert A Fritsche; Carol D Cheli; Thomas A Stamey; Georg Bartsch; Michael K Brawer; Stacy Childs; Samir S Taneja; Herbert Lepor; Alan W Partin; Lori J Sokoll; Daniel W Chan; R Joseph Babaian
Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer.
Urology 2003;62(6):1058-62.
2003: Alan W Partin; Michael K Brawer; Georg Bartsch; Wolfgang Horninger; Samir S Taneja; Herbert Lepor; R Joseph Babaian; Stacy J Childs; Thomas A Stamey; Herbert A Fritsche; Lori J Sokoll; Daniel W Chan; Robert P Thiel; Carol D Cheli
Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial.
The Journal of urology 2003;170(5):1787-91.
2003: Herbert Lepor; Ledia Kaci
Contemporary evaluation of operative parameters and complications related to open radical retropubic prostatectomy.
Urology 2003;62(4):702-6.
2003: Rupa Patel; Joshua Fiske; Herbert Lepor
Tamsulosin reduces the incidence of acute urinary retention following early removal of the urinary catheter after radical retropubic prostatectomy.
Urology 2003;62(2):287-91.
2003: Ojas D Shah; David A Robbins; Jonathan Melamed; Herbert Lepor
The New York University nerve sparing algorithm decreases the rate of positive surgical margins following radical retropubic prostatectomy.
The Journal of urology 2003;169(6):2147-52.
2003: Herbert Lepor
Practical considerations in radical retropubic prostatectomy.
The Urologic clinics of North America 2003;30(2):363-8.
2003: Elias I Hsu; Eugene K Hong; Herbert Lepor
Influence of body weight and prostate volume on intraoperative, perioperative, and postoperative outcomes after radical retropubic prostatectomy.
Urology 2003;61(3):601-6.
2003: Rupa Patel; Herbert Lepor
Removal of urinary catheter on postoperative day 3 or 4 after radical retropubic prostatectomy.
Urology 2003;61(1):156-60.
2003: Tetsuya Takao; Akira Tsujimura; Sandra Coetzee; Sarah N Salm; Herbert Lepor; Ellen Shapiro; David Moscatelli; E Lynette Wilson
Stromal/epithelial interactions of murine prostatic cell lines in vivo: a model for benign prostatic hyperplasia and the effect of doxazosin on tissue size.
The Prostate 2003;54(1):17-24.
2002: Andrew McCullough; K Woo; S Telegrafi; Herbert Lepor
Is sildenafil failure in men after radical retropubic prostatectomy (RRP) due to arterial disease? Penile duplex Doppler findings in 174 men after RRP.
International journal of impotence research 2002;14(6):462-5.
2002: Yoshio Naya; Thomas A Stamey; Carol D Cheli; Alan W Partin; Lori J Sokoll; Daniel W Chan; Michael K Brawer; Samir S Taneja; Herbert Lepor; Georg Bartsch; Stacy Childs; Herbert A Fritsche; R Joseph Babaian
Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?
Urology 2002;60(4 Suppl 1):36-41.
2002: Wolfgang Horninger; Carol D Cheli; R Joseph Babaian; Herbert A Fritsche; Herbert Lepor; Samir S Taneja; Stacy Childs; Thomas A Stamey; Lori J Sokoll; Daniel W Chan; Michael K Brawer; Alan W Partin; Georg Bartsch
Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter.
Urology 2002;60(4 Suppl 1):31-5.
2002: Samir S Taneja; Elias I Hsu; Carol D Cheli; Paul D Walden; Georg Bartsch; Wolfgang Horninger; R Joseph Babaian; Herbert A Fritsche; Stacy Childs; Thomas A Stamey; Lori J Sokoll; Daniel W Chan; Michael K Brawer; Alan W Partin; Herbert Lepor
Complexed prostate-specific antigen as a staging tool: results based on a multicenter prospective evaluation of complexed prostate-specific antigen in cancer diagnosis.
Urology 2002;60(4 Suppl 1):10-7.
2002: Gary K Lefkowitz; Samir S Taneja; Jordan Brown; Jonathan Melamed; Herbert Lepor
Followup interval prostate biopsy 3 years after diagnosis of high grade prostatic intraepithelial neoplasia is associated with high likelihood of prostate cancer, independent of change in prostate specific antigen levels.
The Journal of urology 2002;168(4 Pt 1):1415-8.
2002: Akira Tsujimura; Yasuhiro Koikawa; Sarah N Salm; Tetsuya Takao; Sandra Coetzee; David Moscatelli; Ellen Shapiro; Herbert Lepor; Tung-Tien Sun; E Lynette Wilson
Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis.
The Journal of cell biology 2002;157(7):1257-65.
2002: Xinhua Zhu; Jin Cheng; Jing Gao; Herbert Lepor; Zhong-Ting Zhang; Joanne Pak; Xue-Ru Wu
Isolation of mouse THP gene promoter and demonstration of its kidney-specific activity in transgenic mice.
American journal of physiology. Renal physiology 2002;282(4):F608-17.
2001: Gary K Lefkowitz; G S Sidhu; P Torre; Herbert Lepor; Samir S Taneja
Is repeat prostate biopsy for high-grade prostatic intraepithelial neoplasia necessary after routine 12-core sampling?
Urology 2001;58(6):999-1003.
2001: Herbert Lepor; Alan M Nieder; M N Ferrandino
Intraoperative and postoperative complications of radical retropubic prostatectomy in a consecutive series of 1,000 cases.
The Journal of urology 2001;166(5):1729-33.
2001: Herbert Lepor; Alan M Nieder; MC Fraiman
Early removal of urinary catheter after radical retropubic prostatectomy is both feasible and desirable.
Urology 2001;58(3):425-9.
2001: Herbert Lepor
Radical retropubic prostatectomy.
The Urologic clinics of North America 2001;28(3):509-19, viii.
2001: N Rosenblum; Herbert Lepor
Radical retropubic prostatectomy. Preoperative management.
The Urologic clinics of North America 2001;28(3):499-507.
2001: Samir S Taneja; K Tran; Herbert Lepor
Volume-specific cutoffs are necessary for reproducible application of prostate-specific antigen density of the transition zone in prostate cancer detection.
Urology 2001;58(2):222-7.
2001: Ojas D Shah; Jonathan Melamed; Herbert Lepor
Analysis of apical soft tissue margins during radical retropubic prostatectomy.
The Journal of urology 2001;165(6 Pt 1):1943-8; discussion 1948-9.
2001: R Park; S Martin; Judith D Goldberg; Herbert Lepor
Anastomotic strictures following radical prostatectomy: insights into incidence, effectiveness of intervention, effect on continence, and factors predisposing to occurrence.
Urology 2001;57(4):742-6.
2001: Alan M Nieder; N Rosenblum; Herbert Lepor
Comparison of two different doses of preoperative recombinant erythropoietin in men undergoing radical retropubic prostatectomy.
Urology 2001;57(4):737-41.
2001: Maarten C Bosland; Ikuko Kato; Jonathan Melamed; Samir Taneja; Herbert Lepor; P Torre; Paul D Walden; Anne Zeleniuch-Jacquotte; LH Lumey
Chemoprevention trials in men with prostate-specific antigen failure or at high risk for recurrence after radical prostatectomy: Application to efficacy assessment of soy protein.
Urology 2001;57(4 Suppl 1):202-4.
2001: Patrick C Walsh; Penny L Marschke; William J Catalona; Herbert Lepor; S Martin; R P Myers; M S Steiner
Efficacy of first-generation Cavermap to verify location and function of cavernous nerves during radical prostatectomy: a multi-institutional evaluation by experienced surgeons.
Urology 2001;57(3):491-4.
2000: Sarah N Salm; Yasuhiro Koikawa; V Ogilvie; Akira Tsujimura; Sandra Coetzee; David Moscatelli; E Moore; Herbert Lepor; Ellen Shapiro; Tung-Tien Sun; E Lynette Wilson
Transforming growth factor-beta is an autocrine mitogen for a novel androgen-responsive murine prostatic smooth muscle cell line, PSMC1.
Journal of cellular physiology 2000;185(3):416-24.
2000: Christian Twiss; S Martin; Roy Shore; Herbert Lepor
A continence index predicts the early return of urinary continence after radical retropubic prostatectomy.
The Journal of urology 2000;164(4):1241-7.
2000: Sarah N Salm; Yasuhiro Koikawa; V Ogilvie; Akira Tsujimura; Sandra Coetzee; David Moscatelli; E Moore; Herbert Lepor; Ellen Shapiro; Tung-Tien Sun; E Lynette Wilson
Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines.
Journal of cellular physiology 2000;184(1):70-9.
2000: Herbert Lepor; K Jones; W Williford
The mechanism of adverse events associated with terazosin: an analysis of the Veterans Affairs cooperative study.
The Journal of urology 2000;163(4):1134-7.
2000: N Rosenblum; M A Levine; Toby Handler; Herbert Lepor
The role of preoperative epoetin alfa in men undergoing radical retropubic prostatectomy.
The Journal of urology 2000;163(3):829-33.
2000: K Woo; J Waisman; J Melamed; Herbert Lepor
Primary aldosteronism caused by unilateral adrenal hyperplasia.
Reviews in urology 2000;2(2):100-4.
1999: Samir S Taneja; D F Penson; A Epelbaum; Toby Handler; Herbert Lepor
Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen.
The Journal of urology 1999;162(4):1352-7; discussion 1357-8.
1999: E K Hong; Herbert Lepor; Andrew R McCullough
Time dependent patient satisfaction with sildenafil for erectile dysfunction (ED) after nerve-sparing radical retropubic prostatectomy (RRP).
International journal of impotence research 1999;11 Suppl 1():S15-22.
1999: S M Li; Zhong-Ting Zhang; S Chan; O McLenan; C Dixon; Samir Taneja; Herbert Lepor; Tung-Tien Sun; Xue-Ru Wu
Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder.
The Journal of urology 1999;162(3 Pt 1):931-5.
1999: Paul D Walden; Gary K Lefkowitz; M Ittmann; Herbert Lepor; Marie E Monaco
Mitogenic activation of human prostate-derived fibromuscular stromal cells by bradykinin.
British journal of pharmacology 1999;127(1):220-6.
1999: E J Schwartz; Herbert Lepor
Radical retropubic prostatectomy reduces symptom scores and improves quality of life in men with moderate and severe lower urinary tract symptoms.
The Journal of urology 1999;161(4):1185-8.
1999: Paul D Walden; C Gerardi; Herbert Lepor
Localization and expression of the alpha1A-1, alpha1B and alpha1D-adrenoceptors in hyperplastic and non-hyperplastic human prostate.
The Journal of urology 1999;161(2):635-40.
1998: Herbert Lepor; S Chan; Jonathan Melamed
The role of bladder neck biopsy in men undergoing radical retropubic prostatectomy with preservation of the bladder neck.
The Journal of urology 1998;160(6 Pt 2):2435-9.
1998: Paul D Walden; Gary K Lefkowitz; Michael Ficazzola; J Gitlin; Herbert Lepor
Identification of genes associated with stromal hyperplasia and glandular atrophy of the prostate by mRNA differential display.
Experimental cell research 1998;245(1):19-26.
1998: Herbert Lepor; W O Williford; M J Barry; C Haakenson; K Jones
The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
The Journal of urology 1998;160(4):1358-67.
1998: Ellen Shapiro; M J Seller; Herbert Lepor; D K Kalousek; Grover M Hutchins; Elizabeth J. Perlman; Martin Meuli
Altered smooth muscle development and innervation in the lower genitourinary and gastrointestinal tract of the male human fetus with myelomeningocele.
The Journal of urology 1998;160(3 Pt 2):1047-53; discussion 1079.
1998: K Obara; Herbert Lepor; Paul D Walden
Localization of P2Y1 purinoceptor transcripts in the rat penis and urinary bladder.
The Journal of urology 1998;160(2):587-91.
1998: WC Wong; George Chiu; John M Wetzel; Mohammad R Marzabadi; D Nagarathnam; D Wang; J Fang; SW Miao; X Hong; Carlos Forray; Pierre J Vaysse; Theresa A Branchek; Charles Gluchowski; R Tang; Herbert Lepor
Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.
Journal of medicinal chemistry 1998;41(14):2643-50.
1998: Herbert Lepor
Long-term evaluation of tamsulosin in benign prostatic hyperplasia: placebo-controlled, double-blind extension of phase III trial. Tamsulosin Investigator Group.
Urology 1998;51(6):901-6.
1998: Herbert Lepor
Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Tamsulosin Investigator Group.
Urology 1998;51(6):892-900.
1998: Herbert Lepor
The pathophysiology of lower urinary tract symptoms in the ageing male population.
British journal of urology 1998;81 Suppl 1():29-33.
1998: Paul D Walden; M Ittmann; Marie E Monaco; Herbert Lepor
Endothelin-1 production and agonist activities in cultured prostate-derived cells: implications for regulation of endothelin bioactivity and bioavailability in prostatic hyperplasia.
The Prostate 1998;34(4):241-50.
1998: M A Levine; M Ittman; Jonathan Melamed; Herbert Lepor
Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer.
The Journal of urology 1998;159(2):471-5; discussion 475-6.
1997: TY Chun; S Martin; Herbert Lepor
Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy.
Urology 1997;50(5):727-32.
1997: Ellen Shapiro; Victor H Hartanto; Elizabeth J. Perlman; R Tang; B Wang; Herbert Lepor
Morphometric analysis of pediatric and nonhyperplastic prostate glands: evidence that BPH is not a unique stromal process.
The Prostate 1997;33(3):177-82.
1997: C Imajo; Paul D Walden; Ellen Shapiro; A M Doherty; Herbert Lepor
Evaluation of the effect of endothelin-1 and characterization of the selective endothelin a receptor antagonist PD155080 in the prostate.
The Journal of urology 1997;158(1):253-7.
1997: Herbert Lepor; Alan M Nieder; J Feser; C O'Connell; C Dixon
Total prostate and transition zone volumes, and transition zone index are poorly correlated with objective measures of clinical benign prostatic hyperplasia.
The Journal of urology 1997;158(1):85-8.
1997: Herbert Lepor; Alan M Nieder; J Feser; C O'Connell; C Dixon
Effect of terazosin on prostatism in men with normal and abnormal peak urinary flow rates.
Urology 1997;49(3):476-80.
1997: Paul D Walden; M M Durkin; Herbert Lepor; John M Wetzel; Charles Gluchowski; E L Gustafson
Localization of mRNA and receptor binding sites for the alpha 1a-adrenoceptor subtype in the rat, monkey and human urinary bladder and prostate.
The Journal of urology 1997;157(3):1032-8.
1997: Herbert Lepor; S A Kaplan; I Klimberg; DF Mobley; Ahmed Fawzy; M Gaffney; K Ice; N Dias
Doxazosin for benign prostatic hyperplasia: long-term efficacy and safety in hypertensive and normotensive patients. The Multicenter Study Group.
The Journal of urology 1997;157(2):525-30.
1996: A Hatano; R Tang; P D Walden; Herbert Lepor
The alpha-adrenoceptor antagonist properties of the enantiomers of doxazosin in the human prostate.
European journal of pharmacology 1996;313(1-2):135-43.
1996: Herbert Lepor; W O Williford; Michael J Barry; M K Brawer; C M Dixon; G Gormley; C Haakenson; M Machi; P Narayan; R J Padley
The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
The New England journal of medicine 1996;335(8):533-9.
1996: Herbert Lepor; Ellen Shapiro; B Wang; Y C Liang
Comparison of the cellular composition of benign prostatic hyperplasia in Chinese and Caucasian-American men.
Urology 1996;47(1):38-42.
1995: Herbert Lepor; R Tang; S Kobayashi; Ellen Shapiro; Carlos Forray; John M Wetzel; Charles Gluchowski
Localization of the alpha 1A-adrenoceptor in the human prostate.
The Journal of urology 1995;154(6):2096-9.
1995: Michael J Barry; W O Williford; Y Chang; M Machi; K M Jones; E Walker-Corkery; Herbert Lepor
Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?
The Journal of urology 1995;154(5):1770-4.
1995: Herbert Lepor; C Theune
Randomized double-blind study comparing the efficacy of terazosin versus placebo in women with prostatism-like symptoms.
The Journal of urology 1995;154(1):116-8.
1995: Herbert Lepor
Alpha 1-adrenoceptor selectivity: clinical or theoretical benefit?
British journal of urology 1995;76 Suppl 1():57-61.
1995: Herbert Lepor
The treatment of benign prostatic hyperplasia: a glimpse into the future.
The Urologic clinics of North America 1995;22(2):455-9.
1995: Herbert Lepor
Combination medical therapy for benign prostatic hyperplasia.
The Urologic clinics of North America 1995;22(2):401-5.
1995: Herbert Lepor
Alpha blockade for the treatment of benign prostatic hyperplasia.
The Urologic clinics of North America 1995;22(2):375-86.
1995: Ellen Shapiro; Herbert Lepor
Pathophysiology of clinical benign prostatic hyperplasia.
The Urologic clinics of North America 1995;22(2):285-90.
1995: M Takeda; R Tang; Ellen Shapiro; Arthur L Burnett; Herbert Lepor
Effects of nitric oxide on human and canine prostates.
Urology 1995;45(3):440-6.
1995: Herbert Lepor
Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasia. Terazosin Research Group.
Urology 1995;45(3):406-13.
1994: Herbert Lepor; M Guerena; C M Dixon
Perianastomotic injection of autologous fat at the time of radical retropubic prostatectomy.
Urology 1994;44(5):783-8.
1994: Herbert Lepor; R S Owens; V Rogenes; E Kuhn
Detection of prostate cancer in males with prostatism.
The Prostate 1994;25(3):132-40.
1994: Herbert Lepor; W Zhang; S Kobayashi; R Tang; B Wang; Ellen Shapiro
A comparison of the binding and functional properties of alpha-1 adrenoceptors and area density of smooth muscle in the human, canine and rat prostates.
The Journal of pharmacology and experimental therapeutics 1994;270(2):722-7.
1994: Herbert Lepor; B Wang; Ellen Shapiro
Relationship between prostatic epithelial volume and serum prostate-specific antigen levels.
Urology 1994;44(2):199-205.
1994: Carlos Forray; J A Bard; John M Wetzel; George Chiu; Ellen Shapiro; R Tang; Herbert Lepor; P R Hartig; RL Weinshank; Theresa A Branchek
The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.
Molecular pharmacology 1994;45(4):703-8.
1994: S Kobayashi; R Tang; B Wang; T Opgenorth; E Stein; Ellen Shapiro; Herbert Lepor
Localization of endothelin receptors in the human prostate.
The Journal of urology 1994;151(3):763-6.
1994: S Kobayashi; R Tang; B Wang; T Opgenorth; Peter Langenstroer; Ellen Shapiro; Herbert Lepor
Binding and functional properties of endothelin receptor subtypes in the human prostate.
Molecular pharmacology 1994;45(2):306-11.
1994: Herbert Lepor; Ellen Shapiro
Prostatic alpha adrenoceptors.
Progress in clinical and biological research 1994;386():271-7.
1994: Ellen Shapiro; Herbert Lepor
The pathophysiology of clinical BPH.
Progress in clinical and biological research 1994;386():253-61.
1993: S Kobayashi; R Tang; Ellen Shapiro; Herbert Lepor
Characterization and localization of prostatic alpha 1 adrenoceptors using radioligand receptor binding on slide-mounted tissue section.
The Journal of urology 1993;150(6):2002-6.
1993: Herbert Lepor
Medical therapy for benign prostatic hyperplasia.
Urology 1993;42(5):483-501.
1993: Peter Langenstroer; R Tang; Ellen Shapiro; B Divish; T Opgenorth; Herbert Lepor
Endothelin-1 in the human prostate: tissue levels, source of production and isometric tension studies.
The Journal of urology 1993;150(2 Pt 1):495-9.
1993: Herbert Lepor; R Tang; S Meretyk; Ellen Shapiro
Binding and functional properties of alpha1 adrenoceptors in different regions of the human prostate.
The Journal of urology 1993;150(1):253-6.
1993: Herbert Lepor; G Machi
Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age.
Urology 1993;42(1):36-40; discussion 40-1.
1993: Herbert Lepor; R Tang; S Meretyk; Ellen Shapiro
Alpha 1 adrenoceptor subtypes in the human prostate.
The Journal of urology 1993;149(3):640-2.
1993: Herbert Lepor; R Tang; Ellen Shapiro
The alpha-adrenoceptor subtype mediating the tension of human prostatic smooth muscle.
The Prostate 1993;22(4):301-7.
1992: M Gottlieb; G Anderson; Herbert Lepor
Basic epidemiologic and statistical methods in clinical research.
The Urologic clinics of North America 1992;19(4):641-53.
1992: Herbert Lepor; A Laddu
Terazosin in the treatment of benign prostatic hyperplasia: the United States experience.
British journal of urology 1992;70 Suppl 1():2-9.
1992: Herbert Lepor; S Auerbach; A Puras-Baez; P Narayan; Mark S Soloway; F Lowe; T Moon; G Leifer; P Madsen
A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia.
The Journal of urology 1992;148(5):1467-74.
1992: Herbert Lepor; R Tang; S Meretyk; V Hartanto; Ellen Shapiro
Binding and functional properties of alpha 1 adrenoceptors and area density of smooth muscle in the canine prostate.
The Journal of urology 1992;148(4):1310-3.
1992: Herbert Lepor; I Sunaryadi; V Hartanto; Ellen Shapiro
Quantitative morphometry of the adult human bladder.
The Journal of urology 1992;148(2 Pt 1):414-7.
1992: Herbert Lepor; S Meretyk; G Knapp-Maloney
The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia.
The Journal of urology 1992;147(6):1554-7.
1992: D Dewire; Herbert Lepor
Anatomic considerations of the penis and its lymphatic drainage.
The Urologic clinics of North America 1992;19(2):211-9.
1992: Ellen Shapiro; Michael Becich; V Hartanto; Herbert Lepor
The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia.
The Journal of urology 1992;147(5):1293-7.
1992: D M Dewire; R S Owens; G A Anderson; M S Gottlieb; Herbert Lepor
A comparison of the urological complications associated with long-term management of quadriplegics with and without chronic indwelling urinary catheters.
The Journal of urology 1992;147(4):1069-71; discussion 1071-2.
1992: Ellen Shapiro; V Hartanto; Herbert Lepor
Quantifying the smooth muscle content of the prostate using double-immunoenzymatic staining and color assisted image analysis.
The Journal of urology 1992;147(4):1167-70.
1992: Herbert Lepor; D Sypherd; G Machi; J Derus
Randomized double-blind study comparing the effectiveness of balloon dilation of the prostate and cystoscopy for the treatment of symptomatic benign prostatic hyperplasia.
The Journal of urology 1992;147(3):639-42; discussion 642-4.
1992: Ellen Shapiro; V Hartanto; Herbert Lepor
Anti-desmin vs. anti-actin for quantifying the area density of prostate smooth muscle.
The Prostate 1992;20(4):259-67.
1992: Herbert Lepor; G Machi
The relative efficacy of terazosin versus terazosin and flutamide for the treatment of symptomatic BPH.
The Prostate 1992;20(2):89-95.
1992: S Meretyk; R Tang; Ellen Shapiro; J J Kyncl; Herbert Lepor
Alpha 1-adrenoceptor properties of terazosin HCl and its enantiomers in the human prostate and canine brain.
The Prostate 1992;20(2):159-65.
1992: Ellen Shapiro; V Hartanto; Herbert Lepor
The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscle.
The Prostate 1992;21(4):297-307.
1991: Ellen Shapiro; R Tang; E Rosenthal; Herbert Lepor
The binding and functional properties of voltage dependent calcium channel receptors in pediatric normal and myelodysplastic bladders.
The Journal of urology 1991;146(2 ( Pt 2)):520-3.
1991: Ellen Shapiro; Michael Becich; Elizabeth J. Perlman; Herbert Lepor
Bladder wall abnormalities in myelodysplastic bladders: a computer assisted morphometric analysis.
The Journal of urology 1991;145(5):1024-9.
1991: Herbert Lepor; D Henry; A R Laddu
The efficacy and safety of terazosin for the treatment of symptomatic BPH.
The Prostate 1991;18(4):345-55.
1990: E Rosenthal; Ellen Shapiro; Herbert Lepor
Characterization of 1,4, dihydropyridine calcium channel binding sites in the human prostate.
The Journal of urology 1990;144(6):1539-42.
1990: Herbert Lepor; G Knapp-Maloney; H Sunshine
A dose titration study evaluating terazosin, a selective, once-a-day alpha 1-blocker for the treatment of symptomatic benign prostatic hyperplasia.
The Journal of urology 1990;144(6):1393-7; discussion 1397-8.
1990: Herbert Lepor; Ellen Shapiro; R R Bowsher; D P Henry
Determination of norepinephrine levels in the adult human prostate.
The Journal of urology 1990;144(5):1263-6.
1990: Herbert Lepor
Role of long-acting selective alpha-1 blockers in the treatment of benign prostatic hyperplasia.
The Urologic clinics of North America 1990;17(3):651-9.
1990: Herbert Lepor; Ellen Shapiro
This month in investigative urology: alpha adrenergic innervation of the prostate: insights into pharmacotherapy of BPH.
The Journal of urology 1990;143(3):590-1.
1990: Herbert Lepor; G Rigaud
The efficacy of transurethral resection of the prostate in men with moderate symptoms of prostatism.
The Journal of urology 1990;143(3):533-7.
1990: Herbert Lepor; M Baumann; Ellen Shapiro
Binding and functional properties of doxazosin in the human prostate adenoma and canine brain.
The Prostate 1990;16(1):29-38.
1990: Herbert Lepor
Role of alpha-adrenergic blockers in the treatment of benign prostatic hyperplasia.
The Prostate. Supplement 1990;3():75-84.
1989: Herbert Lepor; G Knapp-Maloney; J Wozniak-Petrofsky
The safety and efficacy of terazosin for the treatment of benign prostatic hyperplasia.
International journal of clinical pharmacology, therapy, and toxicology 1989;27(8):392-7.